Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices by Glenn S. Demby | Jun 8, 2021 | Articles, CMS-lir, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir, Must read... This content is for Paid Members only.RegisterAlready a member? Log in here
AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy by Glenn S. Demby | May 22, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Must read... This content is for Paid Members only.RegisterAlready a member? Log in here
Agency Streamlines Authorization of COVID-19 Molecular Test Pooling for Screening Programs by Glenn S. Demby | May 19, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs by Glenn S. Demby | May 19, 2021 | Articles, CMS-nir, Compliance-nir, Essential, National Lab Reporter, Reimbursement-nir... This content is for Paid Members only.RegisterAlready a member? Log in here
AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here